2026-04-13——
Thermo Fisher's PPD business signs enterprise RWD agreement with HealthVerity
A short entry: a summary of the public record, checked against its sources, not yet read and analysed by Gianluca. How the register works
On April 13, 2026, Thermo Fisher Scientific's PPD clinical research business announced a strategic data collaboration with HealthVerity providing enterprise-level access to HealthVerity's taXonomy claims dataset covering more than 270 million de-identified US patient lives, plus a marketplace of more than 70 curated data sources.
What happened
- Announced April 13, 2026 in Applied Clinical Trials, citing a Thermo Fisher news release the same day.
- PPD gains enterprise-level access to HealthVerity's taXonomy claims dataset covering more than 270 million de-identified patient lives across the US healthcare system.
- The agreement also provides access to a marketplace of more than 70 curated data sources, including electronic medical records, laboratory results, and specialty datasets.
- PPD intends to use the data across trial feasibility, site selection, patient recruitment, and RWE generation, including PPD CorEvitas Clinical Registries and PPD Evidera solutions.
- Krishna Cheriath, vice president and head of clinical research digital and AI at Thermo Fisher Scientific, and Joseph Satili, chief commercial officer at HealthVerity, provided statements on the collaboration.
- Follows a February 11, 2026 PPD collaboration with Datavant integrating tokenization across RCTs, PPD CorEvitas Clinical Registries, and PPD Evidera, over a Datavant ecosystem of more than 350 real-world data partners and approximately 80,000 US hospitals and clinics.
Sources
- appliedclinicaltrialsonline.com — primary
Announced 2026-04-13 · Added to the register 2026-10-01